SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1xls'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1A52_A_ESTA1_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 10 ALA A 272
LEU A 309
ARG A 316
ILE A 345
LEU A 436
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-4.7A)
 1.03A 1a52A-1xlsA:
23.8		 1a52A-1xlsA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1A52_B_ESTB2_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 10 ALA A 272
LEU A 309
ARG A 316
ILE A 345
LEU A 436
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-4.7A)
 1.02A 1a52B-1xlsA:
23.7		 1a52B-1xlsA:
31.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E7B_B_HLTB4002_1
(SERUM ALBUMIN)		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens;
Mus
musculus) 		4 / 4 ARG E 282
ALA A 424
ALA E 327
GLU E 210
 None
 1.24A 1e7bB-1xlsE:
2.1		 1e7bB-1xlsE:
16.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ERE_A_ESTA600_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 9 ALA A 272
LEU A 309
ARG A 316
ILE A 345
LEU A 436
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-4.7A)
 1.03A 1ereA-1xlsA:
25.6		 1ereA-1xlsA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ERE_B_ESTB600_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 9 ALA A 272
LEU A 309
ARG A 316
ILE A 345
LEU A 436
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-4.7A)
 1.03A 1ereB-1xlsA:
25.6		 1ereB-1xlsA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ERE_C_ESTC600_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 9 ALA A 272
LEU A 309
ARG A 316
ILE A 345
LEU A 436
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-4.7A)
 1.03A 1ereC-1xlsA:
25.5		 1ereC-1xlsA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ERE_D_ESTD600_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 9 ALA A 272
LEU A 309
ARG A 316
ILE A 345
LEU A 436
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-4.7A)
 1.03A 1ereD-1xlsA:
25.6		 1ereD-1xlsA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ERE_E_ESTE600_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		4 / 8 ALA A 272
LEU A 309
ARG A 316
LEU A 436
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.7A)
 0.89A 1ereE-1xlsA:
25.6		 1ereE-1xlsA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ERE_F_ESTF600_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		4 / 8 ALA A 272
LEU A 309
ARG A 316
LEU A 436
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.7A)
 0.91A 1ereF-1xlsA:
25.5		 1ereF-1xlsA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ERR_A_RALA600_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
LEU A 276
TRP A 305
ARG A 316
ILE A 428
 9CR  A 801 (-3.5A)
None
None
9CR  A 801 (-2.6A)
None
 1.17A 1errA-1xlsA:
22.1		 1errA-1xlsA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FBY_A_9CRA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		12 / 12 ILE A 268
CYH A 269
ALA A 271
ALA A 272
GLN A 275
PHE A 313
ARG A 316
LEU A 326
ALA A 327
VAL A 342
CYH A 432
HIS A 435
 9CR  A 801 (-3.9A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 3.7A)
None
 0.41A 1fbyA-1xlsA:
33.7		 1fbyA-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FBY_B_9CRB1500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		12 / 12 ILE A 268
CYH A 269
ALA A 271
ALA A 272
GLN A 275
PHE A 313
ARG A 316
LEU A 326
ALA A 327
VAL A 342
CYH A 432
HIS A 435
 9CR  A 801 (-3.9A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 3.7A)
None
 0.39A 1fbyB-1xlsA:
32.9		 1fbyB-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FM6_A_9CRA501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		12 / 12 ILE A 268
ALA A 271
ALA A 272
GLN A 275
TRP A 305
PHE A 313
ARG A 316
LEU A 326
ALA A 327
VAL A 342
CYH A 432
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
None
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 3.7A)
9CR  A 801 (-4.7A)
 0.32A 1fm6A-1xlsA:
36.8		 1fm6A-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FM6_U_9CRU502_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		11 / 12 ALA A 271
ALA A 272
PHE A 313
ARG A 316
LEU A 326
ALA A 327
VAL A 342
ILE A 345
CYH A 432
HIS A 435
LEU A 436
 9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 4.5A)
9CR  A 801 ( 3.7A)
None
9CR  A 801 (-4.7A)
 0.39A 1fm6U-1xlsA:
36.7		 1fm6U-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FM6_U_9CRU502_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		6 / 12 TRP A 305
VAL A 342
ILE A 345
CYH A 432
HIS A 435
LEU A 436
 None
9CR  A 801 ( 4.3A)
9CR  A 801 ( 4.5A)
9CR  A 801 ( 3.7A)
None
9CR  A 801 (-4.7A)
 1.11A 1fm6U-1xlsA:
36.7		 1fm6U-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FM9_A_9CRA201_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		12 / 12 ILE A 268
ALA A 271
ALA A 272
TRP A 305
LEU A 309
PHE A 313
ARG A 316
LEU A 326
ALA A 327
VAL A 342
CYH A 432
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
None
9CR  A 801 (-4.2A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 3.7A)
9CR  A 801 (-4.7A)
 0.32A 1fm9A-1xlsA:
37.5		 1fm9A-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FM9_A_9CRA201_2
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		3 / 3 GLN A 275
ILE A 345
HIS A 435
 9CR  A 801 (-4.7A)
9CR  A 801 ( 4.5A)
None
 0.40A 1fm9A-1xlsA:
37.5		 1fm9A-1xlsA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FXV_B_PNNB1001_0
(PENICILLIN ACYLASE)		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
(Mus
musculus) 		4 / 7 SER E 251
SER E 337
ALA E 335
PHE E 248
 None
None
None
TCD  E 805 (-4.3A)
 1.16A 1fxvA-1xlsE:
undetectable
1fxvB-1xlsE:
undetectable		 1fxvA-1xlsE:
24.50
1fxvB-1xlsE:
15.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1G5Y_B_9CRB501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 TRP A 305
LEU A 309
ARG A 316
LEU A 326
ALA A 327
 None
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
 0.49A 1g5yB-1xlsA:
27.5		 1g5yB-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1G5Y_C_9CRC502_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		6 / 10 LEU A 309
SER A 312
PHE A 313
ARG A 316
LEU A 326
ALA A 327
 9CR  A 801 (-4.2A)
None
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
 0.54A 1g5yC-1xlsA:
27.5		 1g5yC-1xlsA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HWI_B_115B1_1
(HMG-COA REDUCTASE)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 9 CYH A 432
LEU A 451
ALA A 272
LEU A 276
LEU A 309
 9CR  A 801 ( 3.7A)
None
9CR  A 801 (-3.5A)
None
9CR  A 801 (-4.2A)
 1.25A 1hwiA-1xlsA:
undetectable		 1hwiA-1xlsA:
22.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K74_A_9CRA463_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		12 / 12 ILE A 268
ALA A 271
ALA A 272
TRP A 305
LEU A 309
PHE A 313
ARG A 316
LEU A 326
ALA A 327
VAL A 342
CYH A 432
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
None
9CR  A 801 (-4.2A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 3.7A)
9CR  A 801 (-4.7A)
 0.36A 1k74A-1xlsA:
37.4		 1k74A-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K74_A_9CRA463_2
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		3 / 3 GLN A 275
ILE A 345
HIS A 435
 9CR  A 801 (-4.7A)
9CR  A 801 ( 4.5A)
None
 0.34A 1k74A-1xlsA:
37.4		 1k74A-1xlsA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KT3_A_RTLA184_0
(PLASMA
RETINOL-BINDING
PROTEIN)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
ORPHAN NUCLEAR
RECEPTOR NR1I3
(Homo
sapiens;
Mus
musculus) 		4 / 7 LEU E 300
LEU E 302
MET E 323
LEU A 420
 None
 1.06A 1kt3A-1xlsE:
undetectable		 1kt3A-1xlsE:
22.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1PCG_A_ESTA1_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 10 ALA A 272
LEU A 309
ARG A 316
ILE A 345
LEU A 436
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-4.7A)
 0.99A 1pcgA-1xlsA:
25.5		 1pcgA-1xlsA:
32.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1QKN_A_RALA600_1
(ESTROGEN RECEPTOR
BETA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		6 / 12 ALA A 272
LEU A 309
ARG A 316
ILE A 345
ILE A 428
GLY A 429
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
None
None
 1.03A 1qknA-1xlsA:
22.4		 1qknA-1xlsA:
31.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1QKU_A_ESTA600_1
(ESTRADIOL RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 10 ALA A 272
LEU A 309
ARG A 316
ILE A 345
LEU A 436
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-4.7A)
 0.98A 1qkuA-1xlsA:
25.4		 1qkuA-1xlsA:
31.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1QKU_B_ESTB600_1
(ESTRADIOL RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 10 ALA A 272
LEU A 309
ARG A 316
ILE A 345
LEU A 436
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-4.7A)
 0.98A 1qkuB-1xlsA:
25.5		 1qkuB-1xlsA:
31.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1QKU_C_ESTC600_1
(ESTRADIOL RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 10 ALA A 272
LEU A 309
ARG A 316
ILE A 345
LEU A 436
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-4.7A)
 0.98A 1qkuC-1xlsA:
25.5		 1qkuC-1xlsA:
31.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XDK_A_9CRA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		12 / 12 ILE A 268
ALA A 271
GLN A 275
TRP A 305
ASN A 306
PHE A 313
ARG A 316
LEU A 326
ALA A 327
VAL A 342
CYH A 432
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-4.7A)
None
None
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 3.7A)
9CR  A 801 (-4.7A)
 0.40A 1xdkA-1xlsA:
34.9		 1xdkA-1xlsA:
99.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XDK_E_9CRE1500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		12 / 12 ILE A 268
ALA A 271
ALA A 272
GLN A 275
TRP A 305
PHE A 313
ARG A 316
LEU A 326
ALA A 327
VAL A 342
CYH A 432
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
None
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 3.7A)
9CR  A 801 (-4.7A)
 0.40A 1xdkE-1xlsA:
34.9		 1xdkE-1xlsA:
99.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XIU_A_9CRA201_1
(RXR-LIKE PROTEIN)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		12 / 12 ILE A 268
CYH A 269
ALA A 271
ALA A 272
GLN A 275
PHE A 313
ARG A 316
LEU A 326
ALA A 327
VAL A 342
CYH A 432
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 3.7A)
9CR  A 801 (-4.7A)
 0.37A 1xiuA-1xlsA:
31.6		 1xiuA-1xlsA:
82.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XIU_B_9CRB202_1
(RXR-LIKE PROTEIN)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		12 / 12 ILE A 268
ALA A 271
ALA A 272
GLN A 275
LEU A 309
PHE A 313
ARG A 316
ALA A 327
VAL A 342
CYH A 432
HIS A 435
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
9CR  A 801 (-4.2A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 3.7A)
None
9CR  A 801 (-4.7A)
 0.35A 1xiuB-1xlsA:
35.4		 1xiuB-1xlsA:
82.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ACL_A_REAA502_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		11 / 12 ALA A 271
ALA A 272
GLN A 275
ASN A 306
LEU A 309
PHE A 313
ARG A 316
LEU A 326
ALA A 327
ILE A 345
CYH A 432
 9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
None
9CR  A 801 (-4.2A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.5A)
9CR  A 801 ( 3.7A)
 0.47A 2aclA-1xlsA:
29.8
2aclE-1xlsA:
29.6		 2aclA-1xlsA:
100.00
2aclE-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ACL_C_REAC503_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		10 / 10 ILE A 268
ALA A 271
ALA A 272
GLN A 275
ASN A 306
PHE A 313
ARG A 316
ALA A 327
ILE A 345
CYH A 432
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
None
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.5A)
9CR  A 801 ( 3.7A)
 0.45A 2aclC-1xlsA:
29.8		 2aclC-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ACL_E_REAE504_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		11 / 11 ILE A 268
ALA A 271
ALA A 272
GLN A 275
ASN A 306
LEU A 309
PHE A 313
ARG A 316
ALA A 327
ILE A 345
CYH A 432
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
None
9CR  A 801 (-4.2A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.5A)
9CR  A 801 ( 3.7A)
 0.58A 2aclE-1xlsA:
29.6		 2aclE-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ACL_G_REAG501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		12 / 12 ILE A 268
ALA A 271
ALA A 272
GLN A 275
ASN A 306
LEU A 309
ILE A 310
PHE A 313
ARG A 316
LEU A 326
ALA A 327
CYH A 432
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
None
9CR  A 801 (-4.2A)
None
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 3.7A)
 0.78A 2aclG-1xlsA:
28.7		 2aclG-1xlsA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AZQ_A_PCFA954_0
(CATECHOL
1,2-DIOXYGENASE)		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
(Mus
musculus) 		5 / 9 LEU E 253
GLU E 237
HIS E 241
ALA E 239
LEU E 151
 None
None
None
TCD  E 805 ( 4.0A)
None
 1.22A 2azqA-1xlsE:
undetectable		 2azqA-1xlsE:
23.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2J0D_A_ERYA1498_0
(CYTOCHROME P450 3A4)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ARG A 371
ILE A 428
ILE A 345
PHE A 346
ALA A 272
 None
None
9CR  A 801 ( 4.5A)
None
9CR  A 801 (-3.5A)
 1.04A 2j0dA-1xlsA:
undetectable		 2j0dA-1xlsA:
21.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JFA_A_RALA600_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
LEU A 276
TRP A 305
ARG A 316
ILE A 345
 9CR  A 801 (-3.5A)
None
None
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
 0.99A 2jfaA-1xlsA:
22.6		 2jfaA-1xlsA:
26.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JFA_A_RALA600_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
TRP A 305
ARG A 316
ILE A 345
LEU A 436
 9CR  A 801 (-3.5A)
None
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-4.7A)
 0.91A 2jfaA-1xlsA:
22.6		 2jfaA-1xlsA:
26.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JFA_A_RALA600_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
TRP A 305
LEU A 309
ARG A 316
LEU A 436
 9CR  A 801 (-3.5A)
None
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.7A)
 0.86A 2jfaA-1xlsA:
22.6		 2jfaA-1xlsA:
26.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JFA_B_RALB600_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
LEU A 276
TRP A 305
ARG A 316
GLY A 429
 9CR  A 801 (-3.5A)
None
None
9CR  A 801 (-2.6A)
None
 0.97A 2jfaB-1xlsA:
22.6		 2jfaB-1xlsA:
26.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JFA_B_RALB600_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
TRP A 305
LEU A 309
ARG A 316
GLY A 429
 9CR  A 801 (-3.5A)
None
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
None
 0.95A 2jfaB-1xlsA:
22.6		 2jfaB-1xlsA:
26.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JFA_B_RALB600_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
TRP A 305
LEU A 309
ARG A 316
LEU A 436
 9CR  A 801 (-3.5A)
None
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.7A)
 0.85A 2jfaB-1xlsA:
22.6		 2jfaB-1xlsA:
26.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OIQ_A_STIA1001_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens;
Mus
musculus) 		4 / 5 LEU E 313
VAL A 396
LEU A 400
MET E 307
 None
 0.95A 2oiqA-1xlsE:
undetectable		 2oiqA-1xlsE:
22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QX4_B_ML1B233_1
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
(Mus
musculus) 		4 / 7 GLY E 136
GLN E 181
PHE E 177
PHE E 145
 None
 1.23A 2qx4A-1xlsE:
undetectable
2qx4B-1xlsE:
undetectable		 2qx4A-1xlsE:
20.85
2qx4B-1xlsE:
20.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QXS_A_RALA600_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
LEU A 276
TRP A 305
ARG A 316
ILE A 345
 9CR  A 801 (-3.5A)
None
None
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
 1.02A 2qxsA-1xlsA:
23.0		 2qxsA-1xlsA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QXS_A_RALA600_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		6 / 12 ALA A 272
TRP A 305
LEU A 309
ARG A 316
ILE A 345
LEU A 436
 9CR  A 801 (-3.5A)
None
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-4.7A)
 0.95A 2qxsA-1xlsA:
23.0		 2qxsA-1xlsA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QXS_A_RALA600_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
TRP A 305
LEU A 309
ARG A 316
ILE A 428
 9CR  A 801 (-3.5A)
None
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
None
 1.09A 2qxsA-1xlsA:
23.0		 2qxsA-1xlsA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QXS_B_RALB600_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
LEU A 276
TRP A 305
ARG A 316
ILE A 345
 9CR  A 801 (-3.5A)
None
None
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
 1.03A 2qxsB-1xlsA:
22.5		 2qxsB-1xlsA:
31.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QXS_B_RALB600_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		6 / 12 ALA A 272
TRP A 305
LEU A 309
ARG A 316
ILE A 345
LEU A 436
 9CR  A 801 (-3.5A)
None
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-4.7A)
 0.98A 2qxsB-1xlsA:
22.5		 2qxsB-1xlsA:
31.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VCV_E_ASDE1224_1
(GLUTATHIONE
S-TRANSFERASE A3)		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
(Mus
musculus) 		5 / 9 LEU E 123
LEU E 189
LEU E 277
ALA E 273
PHE E 185
 None
 1.22A 2vcvE-1xlsE:
undetectable		 2vcvE-1xlsE:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VCV_H_ASDH1224_1
(GLUTATHIONE
S-TRANSFERASE A3)		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
(Mus
musculus) 		5 / 9 LEU E 123
LEU E 189
LEU E 277
ALA E 273
PHE E 185
 None
 1.26A 2vcvH-1xlsE:
undetectable		 2vcvH-1xlsE:
21.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YJA_B_ESTB1550_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
LEU A 309
ARG A 316
ILE A 345
LEU A 436
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-4.7A)
 1.03A 2yjaB-1xlsA:
25.9		 2yjaB-1xlsA:
31.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2YJA_B_ESTB1550_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
LEU A 309
ARG A 316
ILE A 428
GLY A 429
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
None
None
 1.05A 2yjaB-1xlsA:
25.9		 2yjaB-1xlsA:
31.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CFQ_A_DIFA1_1
(TRANSTHYRETIN)		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
(Mus
musculus) 		4 / 6 LEU E 191
ALA E 274
LEU E 294
THR E 275
 None
 0.94A 3cfqA-1xlsE:
undetectable		 3cfqA-1xlsE:
20.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DZU_A_9CRA7223_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		11 / 12 ALA A 271
GLN A 275
ASN A 306
ILE A 310
PHE A 313
ARG A 316
LEU A 326
VAL A 342
CYH A 432
HIS A 435
LEU A 436
 9CR  A 801 (-3.6A)
9CR  A 801 (-4.7A)
None
None
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 3.7A)
None
9CR  A 801 (-4.7A)
 0.64A 3dzuA-1xlsA:
32.9		 3dzuA-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DZU_A_9CRA7223_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		11 / 12 ILE A 268
ALA A 271
GLN A 275
ILE A 310
PHE A 313
ARG A 316
LEU A 326
VAL A 342
CYH A 432
HIS A 435
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-4.7A)
None
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 3.7A)
None
9CR  A 801 (-4.7A)
 0.51A 3dzuA-1xlsA:
32.9		 3dzuA-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DZY_A_9CRA463_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		6 / 12 ALA A 271
GLN A 275
ASN A 306
ARG A 316
ALA A 327
LEU A 455
 9CR  A 801 (-3.6A)
9CR  A 801 (-4.7A)
None
9CR  A 801 (-2.6A)
9CR  A 801 (-3.3A)
None
 1.31A 3dzyA-1xlsA:
31.0		 3dzyA-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DZY_A_9CRA463_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		11 / 12 ILE A 268
ALA A 271
GLN A 275
ASN A 306
PHE A 313
ARG A 316
LEU A 326
ALA A 327
VAL A 342
CYH A 432
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-4.7A)
None
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 3.7A)
9CR  A 801 (-4.7A)
 0.66A 3dzyA-1xlsA:
31.0		 3dzyA-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3E00_A_9CRA7223_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		12 / 12 ILE A 268
ALA A 271
ALA A 272
GLN A 275
TRP A 305
ASN A 306
PHE A 313
ARG A 316
ALA A 327
VAL A 342
ILE A 345
CYH A 432
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
None
None
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 4.5A)
9CR  A 801 ( 3.7A)
 0.42A 3e00A-1xlsA:
33.3		 3e00A-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3E00_A_9CRA7223_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		6 / 12 ILE A 268
ALA A 271
GLN A 275
PHE A 313
VAL A 342
ILE A 345
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-4.7A)
9CR  A 801 (-4.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 4.5A)
 1.37A 3e00A-1xlsA:
33.3		 3e00A-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3FAL_A_REAA501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		10 / 10 ILE A 268
ALA A 271
ALA A 272
GLN A 275
PHE A 313
ARG A 316
ALA A 327
VAL A 342
ILE A 345
CYH A 432
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 4.5A)
9CR  A 801 ( 3.7A)
 0.37A 3falA-1xlsA:
29.3		 3falA-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3FAL_C_REAC501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		10 / 10 ILE A 268
ALA A 271
ALA A 272
GLN A 275
PHE A 313
ARG A 316
LEU A 326
ALA A 327
ILE A 345
CYH A 432
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.5A)
9CR  A 801 ( 3.7A)
 0.32A 3falC-1xlsA:
29.4		 3falC-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3FC6_A_REAA501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		11 / 11 ILE A 268
ALA A 271
ALA A 272
GLN A 275
TRP A 305
PHE A 313
ARG A 316
LEU A 326
ALA A 327
ILE A 345
CYH A 432
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
None
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.5A)
9CR  A 801 ( 3.7A)
 0.42A 3fc6A-1xlsA:
30.0		 3fc6A-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3FC6_C_REAC501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		6 / 12 VAL A 265
ALA A 271
GLN A 275
PHE A 313
ARG A 316
VAL A 342
 9CR  A 801 ( 4.6A)
9CR  A 801 (-3.6A)
9CR  A 801 (-4.7A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.3A)
 1.50A 3fc6C-1xlsA:
30.5		 3fc6C-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3FC6_C_REAC501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		12 / 12 VAL A 265
CYH A 269
ALA A 271
ALA A 272
GLN A 275
LEU A 309
PHE A 313
ARG A 316
LEU A 326
ALA A 327
VAL A 342
CYH A 432
 9CR  A 801 ( 4.6A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
9CR  A 801 (-4.2A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 3.7A)
 0.38A 3fc6C-1xlsA:
30.5		 3fc6C-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3H0A_A_9RAA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		7 / 12 ALA A 271
ALA A 272
GLN A 275
ARG A 316
LEU A 326
ALA A 327
ILE A 428
 9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
None
 1.30A 3h0aA-1xlsA:
31.5		 3h0aA-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3H0A_A_9RAA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		11 / 12 ALA A 271
ALA A 272
GLN A 275
TRP A 305
LEU A 309
ARG A 316
LEU A 326
ALA A 327
VAL A 342
ILE A 345
LEU A 436
 9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
None
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-4.7A)
 0.71A 3h0aA-1xlsA:
31.5		 3h0aA-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3H0A_A_9RAA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		9 / 12 ALA A 271
ALA A 272
LEU A 309
ARG A 316
LEU A 326
ALA A 327
VAL A 342
ILE A 345
CYH A 432
 9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 4.5A)
9CR  A 801 ( 3.7A)
 0.81A 3h0aA-1xlsA:
31.5		 3h0aA-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3H0A_A_9RAA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		6 / 12 ALA A 271
GLN A 275
ARG A 316
ALA A 327
VAL A 342
ILE A 345
 9CR  A 801 (-3.6A)
9CR  A 801 (-4.7A)
9CR  A 801 (-2.6A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 4.5A)
 1.44A 3h0aA-1xlsA:
31.5		 3h0aA-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3H0A_A_9RAA500_2
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		3 / 3 ILE A 268
PHE A 313
HIS A 435
 9CR  A 801 (-3.9A)
9CR  A 801 (-4.3A)
None
 0.54A 3h0aA-1xlsA:
31.5		 3h0aA-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OAP_A_9CRA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		12 / 12 ILE A 268
ALA A 271
ALA A 272
GLN A 275
PHE A 313
ARG A 316
LEU A 326
ALA A 327
VAL A 342
ILE A 345
CYH A 432
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 4.5A)
9CR  A 801 ( 3.7A)
9CR  A 801 (-4.7A)
 0.34A 3oapA-1xlsA:
35.6		 3oapA-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OLS_B_ESTB600_1
(ESTROGEN RECEPTOR
BETA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
LEU A 309
ARG A 316
ILE A 345
LEU A 436
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-4.7A)
 1.04A 3olsB-1xlsA:
25.2		 3olsB-1xlsA:
30.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3Q95_A_ESLA700_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
LEU A 309
ARG A 316
ILE A 428
GLY A 429
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
None
None
 1.00A 3q95A-1xlsA:
26.0		 3q95A-1xlsA:
30.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3Q95_B_ESLB700_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
LEU A 309
ARG A 316
ILE A 428
GLY A 429
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
None
None
 1.04A 3q95B-1xlsA:
25.4		 3q95B-1xlsA:
30.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S8P_B_SAMB500_1
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV420H1)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
ORPHAN NUCLEAR
RECEPTOR NR1I3
(Homo
sapiens;
Mus
musculus) 		3 / 3 HIS E 254
SER E 331
ASN A 377
 None
 0.67A 3s8pB-1xlsE:
1.5		 3s8pB-1xlsE:
21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3THR_A_C2FA1100_0
(GLYCINE
N-METHYLTRANSFERASE)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
ORPHAN NUCLEAR
RECEPTOR NR1I3
(Homo
sapiens;
Mus
musculus) 		4 / 6 SER A 355
LEU A 353
THR A 351
ARG E 288
 None
 1.03A 3thrB-1xlsA:
undetectable		 3thrB-1xlsA:
22.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UVV_B_9CRB501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		11 / 12 ILE A 268
ALA A 271
ALA A 272
GLN A 275
LEU A 309
PHE A 313
ARG A 316
ALA A 327
VAL A 342
CYH A 432
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
9CR  A 801 (-4.2A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 3.7A)
9CR  A 801 (-4.7A)
 0.43A 3uvvB-1xlsA:
36.0		 3uvvB-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UVV_B_9CRB501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		11 / 12 ILE A 268
ALA A 271
ALA A 272
GLN A 275
LEU A 309
PHE A 313
ARG A 316
ALA A 327
VAL A 342
ILE A 345
CYH A 432
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
9CR  A 801 (-4.2A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 4.5A)
9CR  A 801 ( 3.7A)
 0.47A 3uvvB-1xlsA:
36.0		 3uvvB-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UVV_B_9CRB501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		6 / 12 ILE A 268
ALA A 271
GLN A 275
PHE A 313
VAL A 342
ILE A 345
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-4.7A)
9CR  A 801 (-4.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 4.5A)
 1.47A 3uvvB-1xlsA:
36.0		 3uvvB-1xlsA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4I89_A_1FLA201_1
(TRANSTHYRETIN)		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
(Mus
musculus) 		4 / 6 LEU E 191
ALA E 274
LEU E 294
THR E 275
 None
 1.02A 4i89A-1xlsE:
undetectable		 4i89A-1xlsE:
20.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4K6I_A_9RAA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		11 / 12 ILE A 268
ALA A 271
ALA A 272
GLN A 275
LEU A 309
ILE A 310
PHE A 313
ARG A 316
LEU A 326
ALA A 327
VAL A 349
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
9CR  A 801 (-4.2A)
None
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
None
 0.37A 4k6iA-1xlsA:
35.3		 4k6iA-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4K6I_A_9RAA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		9 / 12 ILE A 268
ALA A 271
LEU A 309
ILE A 310
PHE A 313
ARG A 316
LEU A 326
ALA A 327
CYH A 432
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-4.2A)
None
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 3.7A)
 0.69A 4k6iA-1xlsA:
35.3		 4k6iA-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4K6I_A_9RAA500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 LEU A 309
ILE A 310
PHE A 313
ALA A 271
VAL A 349
 9CR  A 801 (-4.2A)
None
9CR  A 801 (-4.3A)
9CR  A 801 (-3.6A)
None
 1.06A 4k6iA-1xlsA:
35.3		 4k6iA-1xlsA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LTW_A_486A303_1
(ANCESTRAL STEROID
RECEPTOR 2)		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
(Mus
musculus) 		5 / 9 LEU E 189
LEU E 203
GLN E 295
PHE E 278
LEU E 123
 None
 1.35A 4ltwA-1xlsE:
20.0		 4ltwA-1xlsE:
23.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NQA_A_9CRA501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		10 / 11 ILE A 268
ALA A 272
GLN A 275
PHE A 313
ARG A 316
LEU A 326
ALA A 327
CYH A 432
HIS A 435
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 3.7A)
None
9CR  A 801 (-4.7A)
 0.53A 4nqaA-1xlsA:
34.0		 4nqaA-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NQA_A_9CRA501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		10 / 11 ILE A 268
ALA A 272
GLN A 275
PHE A 313
LEU A 326
ALA A 327
VAL A 342
CYH A 432
HIS A 435
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
9CR  A 801 (-4.3A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 3.7A)
None
9CR  A 801 (-4.7A)
 0.37A 4nqaA-1xlsA:
34.0		 4nqaA-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NQA_H_9CRH501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		11 / 12 ILE A 268
ALA A 271
ALA A 272
GLN A 275
PHE A 313
ARG A 316
LEU A 326
ALA A 327
CYH A 432
HIS A 435
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 3.7A)
None
9CR  A 801 (-4.7A)
 0.50A 4nqaH-1xlsA:
34.1		 4nqaH-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NQA_H_9CRH501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		6 / 12 ILE A 268
ALA A 272
ILE A 345
CYH A 432
HIS A 435
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.5A)
9CR  A 801 ( 4.5A)
9CR  A 801 ( 3.7A)
None
9CR  A 801 (-4.7A)
 0.54A 4nqaH-1xlsA:
34.1		 4nqaH-1xlsA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PXM_B_ESTB2000_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 11 ALA A 272
LEU A 309
ARG A 316
ILE A 345
LEU A 436
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-4.7A)
 1.02A 4pxmB-1xlsA:
25.5		 4pxmB-1xlsA:
29.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PXM_B_ESTB2000_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 11 ALA A 272
LEU A 309
ARG A 316
ILE A 428
GLY A 429
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
None
None
 1.04A 4pxmB-1xlsA:
25.5		 4pxmB-1xlsA:
29.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WQ4_A_ACTA403_0
(TRNA N6-ADENOSINE
THREONYLCARBAMOYLTRA
NSFERASE)		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
(Mus
musculus) 		3 / 3 VAL E 124
LEU E 128
VAL E 270
 None
 0.59A 4wq4A-1xlsE:
undetectable		 4wq4A-1xlsE:
23.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XI3_B_29SB601_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
LEU A 309
ARG A 316
ILE A 428
GLY A 429
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
None
None
 0.99A 4xi3B-1xlsA:
22.8		 4xi3B-1xlsA:
31.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XI3_B_29SB601_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
TRP A 305
LEU A 309
ARG A 316
GLY A 429
 9CR  A 801 (-3.5A)
None
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
None
 0.91A 4xi3B-1xlsA:
22.8		 4xi3B-1xlsA:
31.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XI3_B_29SB601_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
TRP A 305
LEU A 309
ARG A 316
LEU A 436
 9CR  A 801 (-3.5A)
None
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.7A)
 0.92A 4xi3B-1xlsA:
22.8		 4xi3B-1xlsA:
31.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XI3_B_29SB601_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
TRP A 305
LEU A 309
ILE A 345
LEU A 436
 9CR  A 801 (-3.5A)
None
9CR  A 801 (-4.2A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-4.7A)
 0.86A 4xi3B-1xlsA:
22.8		 4xi3B-1xlsA:
31.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XI3_C_29SC601_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
TRP A 305
LEU A 309
ARG A 316
GLY A 429
 9CR  A 801 (-3.5A)
None
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
None
 0.91A 4xi3C-1xlsA:
22.2		 4xi3C-1xlsA:
31.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XI3_C_29SC601_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
TRP A 305
LEU A 309
ARG A 316
LEU A 436
 9CR  A 801 (-3.5A)
None
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.7A)
 0.92A 4xi3C-1xlsA:
22.2		 4xi3C-1xlsA:
31.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XI3_D_29SD601_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 12 ALA A 272
TRP A 305
LEU A 309
ARG A 316
LEU A 436
 9CR  A 801 (-3.5A)
None
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.7A)
 0.91A 4xi3D-1xlsA:
22.4		 4xi3D-1xlsA:
31.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XOY_A_DX4A401_0
(MITOGEN-ACTIVATED
PROTEIN KINASE 1)		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
(Mus
musculus) 		4 / 6 ALA E 299
GLN E 295
LEU E 302
LEU E 326
 None
 1.18A 4xoyA-1xlsE:
undetectable		 4xoyA-1xlsE:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BOJ_A_4TXA201_1
(TRANSTHYRETIN)		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
(Mus
musculus) 		4 / 6 LEU E 191
ALA E 274
LEU E 294
THR E 275
 None
 1.02A 5bojA-1xlsE:
undetectable		 5bojA-1xlsE:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CPR_B_SAMB402_1
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV420H1)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
ORPHAN NUCLEAR
RECEPTOR NR1I3
(Homo
sapiens;
Mus
musculus) 		3 / 3 HIS E 254
SER E 331
ASN A 377
 None
 0.57A 5cprB-1xlsE:
undetectable		 5cprB-1xlsE:
21.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DXB_B_ESTB601_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 11 ALA A 272
LEU A 309
ARG A 316
ILE A 345
LEU A 436
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-4.7A)
 1.02A 5dxbB-1xlsA:
25.6		 5dxbB-1xlsA:
29.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DXB_B_ESTB601_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 11 ALA A 272
LEU A 309
ARG A 316
ILE A 428
GLY A 429
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
None
None
 1.03A 5dxbB-1xlsA:
25.6		 5dxbB-1xlsA:
29.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HNZ_B_TA1B902_2
(TUBULIN BETA-2B
CHAIN)		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens;
Mus
musculus) 		3 / 3 LEU E 322
LEU E 302
ARG A 414
 None
 0.61A 5hnzB-1xlsE:
undetectable		 5hnzB-1xlsE:
18.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IEP_A_VDYA201_2
(CDL2.3B)		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
(Mus
musculus) 		5 / 9 ILE E 332
VAL E 179
LEU E 353
ILE E 356
LEU E 249
 None
None
TCD  E 805 (-4.2A)
None
None
 1.08A 5iepA-1xlsE:
0.7		 5iepA-1xlsE:
19.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5JI0_A_9CRA501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		11 / 11 ILE A 268
GLN A 275
TRP A 305
LEU A 309
PHE A 313
ARG A 316
LEU A 326
ALA A 327
VAL A 342
CYH A 432
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-4.7A)
None
9CR  A 801 (-4.2A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 3.7A)
9CR  A 801 (-4.7A)
 0.34A 5ji0A-1xlsA:
34.7		 5ji0A-1xlsA:
99.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JS5_A_ASCA202_0
(CYTOCHROME C')		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		3 / 3 CYH A 404
LYS A 407
HIS A 406
 None
 1.22A 5js5A-1xlsA:
0.5		 5js5A-1xlsA:
22.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MM4_B_TA1B501_1
(TUBULIN BETA CHAIN)		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
(Mus
musculus) 		5 / 10 LEU E 253
ALA E 242
PHE E 171
PRO E 148
LEU E 151
 None
None
TCD  E 805 ( 4.7A)
None
None
 1.32A 5mm4B-1xlsE:
undetectable		 5mm4B-1xlsE:
13.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NWV_A_ACAA18_2
(SCRFP-TAG,GP41)		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
(Mus
musculus) 		4 / 7 GLN E 144
ASP E 173
ALA E 172
LEU E 353
 None
None
TCD  E 805 ( 4.3A)
TCD  E 805 (-4.2A)
 1.05A 5nwvA-1xlsE:
undetectable		 5nwvA-1xlsE:
10.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5SYE_B_TA1B502_1
(TUBULIN BETA CHAIN)		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens;
Mus
musculus) 		5 / 12 ALA E 276
SER E 279
ARG E 330
PRO A 423
GLY E 324
 None
 1.30A 5syeB-1xlsE:
undetectable		 5syeB-1xlsE:
18.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5UAN_A_9CRA503_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		12 / 12 ILE A 268
ALA A 271
ALA A 272
GLN A 275
TRP A 305
PHE A 313
ARG A 316
LEU A 326
ALA A 327
VAL A 342
CYH A 432
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
None
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 3.7A)
9CR  A 801 (-4.7A)
 0.52A 5uanA-1xlsA:
33.1		 5uanA-1xlsA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UH6_C_RFPC1201_1
(DNA-DIRECTED RNA
POLYMERASE SUBUNIT
BETA)		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens;
Mus
musculus) 		5 / 12 GLN E 245
LEU E 249
ASP A 379
HIS E 254
ILE E 332
 None
 1.48A 5uh6C-1xlsE:
undetectable		 5uh6C-1xlsE:
11.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5Z12_B_9CRB501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		12 / 12 ILE A 268
ALA A 271
ALA A 272
TRP A 305
LEU A 309
PHE A 313
ARG A 316
LEU A 326
ALA A 327
VAL A 342
CYH A 432
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
None
9CR  A 801 (-4.2A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 3.7A)
9CR  A 801 (-4.7A)
 0.33A 5z12B-1xlsA:
35.4		 5z12B-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5Z12_B_9CRB501_2
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		3 / 3 GLN A 275
ILE A 345
HIS A 435
 9CR  A 801 (-4.7A)
9CR  A 801 ( 4.5A)
None
 0.49A 5z12B-1xlsA:
35.4		 5z12B-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5Z12_C_9CRC501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		12 / 12 ILE A 268
ALA A 271
ALA A 272
GLN A 275
TRP A 305
PHE A 313
ARG A 316
LEU A 326
ALA A 327
VAL A 342
CYH A 432
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
None
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.3A)
9CR  A 801 ( 3.7A)
9CR  A 801 (-4.7A)
 0.42A 5z12C-1xlsA:
33.0		 5z12C-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A5Y_D_9CRD501_0
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		6 / 12 ALA A 271
ALA A 272
GLN A 275
TRP A 305
ALA A 327
LEU A 455
 9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
None
9CR  A 801 (-3.3A)
None
 1.32A 6a5yD-1xlsA:
34.9		 6a5yD-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A5Y_D_9CRD501_0
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		12 / 12 ILE A 268
ALA A 271
ALA A 272
GLN A 275
TRP A 305
PHE A 313
ARG A 316
LEU A 326
ALA A 327
ILE A 345
CYH A 432
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
None
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.5A)
9CR  A 801 ( 3.7A)
9CR  A 801 (-4.7A)
 0.40A 6a5yD-1xlsA:
34.9		 6a5yD-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A5Y_D_9CRD501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		3 / 3 ASN A 306
VAL A 342
HIS A 435
 None
9CR  A 801 ( 4.3A)
None
 0.24A 6a5yD-1xlsA:
34.9		 6a5yD-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A5Z_D_9CRD501_0
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		12 / 12 ILE A 268
ALA A 271
ALA A 272
GLN A 275
ILE A 310
PHE A 313
ARG A 316
LEU A 326
ALA A 327
ILE A 345
CYH A 432
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
None
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.5A)
9CR  A 801 ( 3.7A)
9CR  A 801 (-4.7A)
 0.31A 6a5zD-1xlsA:
35.4		 6a5zD-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A5Z_L_9CRL501_0
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		12 / 12 ILE A 268
ALA A 271
ALA A 272
GLN A 275
PHE A 313
ARG A 316
LEU A 326
ALA A 327
ILE A 345
CYH A 432
HIS A 435
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-4.1A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.5A)
9CR  A 801 ( 3.7A)
None
9CR  A 801 (-4.7A)
 0.34A 6a5zL-1xlsA:
34.7		 6a5zL-1xlsA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A60_D_9CRD501_0
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		12 / 12 ILE A 268
ALA A 271
ALA A 272
GLN A 275
LEU A 309
PHE A 313
ARG A 316
ALA A 327
ILE A 345
CYH A 432
HIS A 435
LEU A 436
 9CR  A 801 (-3.9A)
9CR  A 801 (-3.6A)
9CR  A 801 (-3.5A)
9CR  A 801 (-4.7A)
9CR  A 801 (-4.2A)
9CR  A 801 (-4.3A)
9CR  A 801 (-2.6A)
9CR  A 801 (-3.3A)
9CR  A 801 ( 4.5A)
9CR  A 801 ( 3.7A)
None
9CR  A 801 (-4.7A)
 0.40A 6a60D-1xlsA:
35.0		 6a60D-1xlsA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AJI_A_AY6A1001_0
(DRUG EXPORTERS OF
THE RND
SUPERFAMILY-LIKE
PROTEIN,ENDOLYSIN)		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
(Mus
musculus) 		5 / 12 LEU E 151
PHE E 228
VAL E 240
ALA E 242
LEU E 167
 None
 1.15A 6ajiA-1xlsE:
undetectable		 6ajiA-1xlsE:
13.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CBZ_B_ESTB602_1
(ESTROGEN RECEPTOR)		 1xls RETINOIC ACID
RECEPTOR RXR-ALPHA
(Homo
sapiens) 		5 / 10 ALA A 272
LEU A 309
ARG A 316
ILE A 345
LEU A 436
 9CR  A 801 (-3.5A)
9CR  A 801 (-4.2A)
9CR  A 801 (-2.6A)
9CR  A 801 ( 4.5A)
9CR  A 801 (-4.7A)
 1.04A 6cbzB-1xlsA:
25.6		 6cbzB-1xlsA:
18.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G1P_B_ACTB403_0
(ADP-RIBOSYLHYDROLASE
LIKE 2)		 1xls ORPHAN NUCLEAR
RECEPTOR NR1I3
(Mus
musculus) 		3 / 3 PHE E 145
ARG E 146
GLN E 144
 None
 1.18A 6g1pB-1xlsE:
0.3		 6g1pB-1xlsE:
21.35